Poultry
xClose

Loading ...
Swine
xClose

Loading ...
Dairy & Ruminant
xClose

Loading ...
Aquaculture
xClose

Loading ...
Feed
xClose

Loading ...
Animal Health
xClose

Loading ...
Animal Health
Friday, September 14, 2012 7:10:17 PM
Print this articleForward this article

 

Prophylactic treatment with flumethrin, a pyrethroid (Bayticol(R), Bayer), against Anaplasma phagocytophilum infection in lambs

 
Snorre Stuen, Jörg MD Enemark, Karin Artursson and Bent Nielsen
 
 

Background


Anaplasma phagocytophilum (formerly Ehrlichia phagocytophila) causes the disease tickborne fever (TBF) in domestic ruminants and has for decades been one of the main scourges for the sheep industry in the coastal areas of Norway. Current control strategies are based on reduction of tick infestation by chemical acaricides.

 

Methods


In the present study, we investigated if frequent pour-on applications of pyrethroids would reduce tick infestion rate and seroprevalence of A. phagocytophilum infection in sheep. Forty lambs, one month old, of the Norwegian White Sheep breed were used. The lambs belonged to the experimental sheep flock at the Department of Production Animal Clinical Sciences.

 

None of the lambs had been on I. ricinus infested pasture before turnout (day 0). All lambs were twins and twenty lambs were treated with a pour-on pyrethroid (Bayticol(R), Bayer A/S, DK-2300) with a dose of 5 ml on days 0, 14, 28, 42, 56, 70, 84, 98, 112 and 128. Twenty lambs were untreated controls. The lambs were collected every fourteen days on pasture for treatment. In addition, the lambs were examined for ticks, blood sampled, weighed, and rectal temperature was recorded.

 

Results and conclusion


A significant reduction in tick infestion rate was detected on treated lambs. However, the present results indicate that frequent acaricide treatment does not reduce the seroprevalence to A. phagocytophilum on tick-infested pasture.

 


For more of the article, please click here.


Article made possible through the contribution of Snorre Stuen, Jörg MD Enemark, Karin Artursson, Bent Nielsen and BioMed Central.

Share this article on FacebookShare this article on TwitterPrint this articleForward this article
Previous
My eFeedLink last read